We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Emergent BioSolutions on Tuesday announced that it entered into an agreement to acquire Adapt Pharma for up to $735 million, gaining the latter's Narcan (naloxone) nasal spray. Daniel Abdun-Nabi......
Adapt Pharma will donate 20,000 cartons (40,000 doses) of NARCAN® (naloxone hydrochloride) Nasal Spray 4mg to colleges and universities throughout the United States.